HPK1 antagonists and uses thereof
US12215105B2 · kind B2 · utility
0Cited by
16References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2020 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Jan 10, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.